Search the Newsreel

ANVS: Alzheimer's Phase 3 trial fully enrolled; R&D costs and net loss per share increased year-over-year

Annovis Bio (ANVS) has fully enrolled its pivotal Alzheimer's Phase 3 trial, with topline data anticipated in Q1 2027. The company experienced a sharp increase in research and development expenses, leading to a higher net loss per share year-over-year. Additionally, enrollment continues for the …

Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, disclosing beneficial ownership of 3,900,000 shares of Enovis Corporation (ENOV) common stock. This position represents 6.78% of the company's outstanding shares, based on 57,562,603 shares as of May 1, 2026. Both …

Bank of America Revamps Lenovo Stock Price Target for 2026

This article first appeared on GuruFocus. Bank of America upgraded Lenovo (LNVGF) (LNVGY) to Buy from Neutral after a blowout fiscal first quarter, arguing that a sharp acceleration in servers is changing the earnings profile of a company still widely associated with PCs. The …

SS Innovations International (SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%

SS Innovations International (SSII) announced record second-quarter 2026 revenue of $13.9 million, a 39.4% increase year-over-year, driven by a 30.4% rise in SSi Mantra surgical robotic system installations. The company reported a gross profit of $7.1 million and a cumulative installed base of 224 …

Innovative Eyewear Inc Q2 2026: Revenue $1.01M, EPS $(0.26) — 10-Q Summary

Innovative Eyewear Inc (LUCY) reported Q2 2026 results showing a significant revenue increase to $1.01M, a 74% year-over-year rise, driven by strong unit volume and expanded retail presence. The company also narrowed its net loss to $1.67M from $2.11M in Q2 2025, with diluted …

Novavax Inc. stock underperforms Friday when compared to competitors

Novavax Inc. (NVAX) shares dropped 1.11% on Friday, closing at $8.05, despite a three-day winning streak being snapped. This underperformance occurred on a negative trading day for the broader market, with both the NASDAQ Composite and Dow Jones Industrial Average also experiencing declines.

Fortune Brands Innovations Inc. stock underperforms Friday when compared to competitors

Fortune Brands Innovations Inc. (FBIN) stock fell 1.22% on Friday, closing at $47.84. This underperformance occurred during a generally negative trading session where both the S&P 500 Index and the Dow Jones Industrial Average also declined. It marked the third consecutive day of losses …

3 Reasons Why Growth Investors Shouldn't Overlook Enova International (ENVA)

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all. In addition to volatility, these stocks carry above-average …

Innovative Eyewear (LUCY) grows revenue 74% but stays unprofitable in Q2 2026

Innovative Eyewear, Inc. (LUCY) reported a 74% increase in revenue for Q2 2026, reaching $1,010,519, primarily driven by strong sales of Lucyd Armor smart safety glasses and Reebok-branded smartglasses. Despite the significant revenue growth and improved gross margin of 24%, the company continued to …

Innovative Eyewear Reports 74% Revenue Growth in Q2

Innovative Eyewear reported a significant 74% year-over-year revenue growth in Q2 2026, reaching over $1 million for the first time. The company also improved its gross margin to 24% and reduced operating expenses, demonstrating effective cost management. With strategic initiatives and partnerships, Innovative Eyewear …

Cenovus Energy Inc. stock rises Friday, outperforms market

Cenovus Energy Inc. (CVE) shares rose 1.01% on Friday to C$43.11, outperforming the broader Canadian market. The S&P/TSX Composite Index fell 0.08%, while Cenovus Energy Inc. closed 2.3% below its 52-week high. The company's stock reached its 52-week high of C$44.13 on May 20th.

Novo Nordisk Aktie (NOV) • DK0062498333

Innovative Eyewear Q2 EPS $(0.26) beats estimate, sales rise 74%

Highbridge Capital (ANVS) discloses 6.1% Annovis Bio stake tied to 2.78M warrant shares

Highbridge Capital Management, LLC has disclosed a beneficial ownership of 6.1% in Annovis Bio, Inc., which is tied to 2,775,578 shares of common stock issuable upon the exercise of warrants. This stake is calculated based on 42,541,868 outstanding common shares after a referenced offering …

Will Bank of Nova Scotia (BNS) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Bank of Nova Scotia (BNS). This company, which is in …

Enova International (NYSE:ENVA) Hits New 52-Week High - Should You Buy?

Enova International (NYSE:ENVA) recently hit a new 52-week high of $266.99, with a market capitalization of $6.6 billion. The company surpassed quarterly expectations, reporting $4.31 EPS and $928.93 million in revenue, up 21.6% year-over-year. Despite a consensus "Buy" rating from analysts, some insider selling …

Should Investors Take Profits in GE Vernova After Its Big Run?

GE Vernova stock has surged 674% since its spinoff, driven by massive demand for its power equipment from AI data centers, leading to a $176 billion backlog. While its valuation is high, reflecting strong growth prospects, early investors might consider taking some profits to …

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

Inovio Pharmaceuticals Inc. (INO) shares surged 21.10% to $1.09 on Friday, outperforming the broader market as the NASDAQ Composite Index and Dow Jones Industrial Average both experienced declines. This marked the fifth consecutive day of gains for Inovio's stock, despite a generally rough trading …

Annovis Bio Sees Unusually Large Options Volume (NYSE:ANVS)

Annovis Bio (NYSE:ANVS) experienced unusual options trading volume on Friday, with traders buying 3,595 put options, a 139% increase over its typical daily volume. Despite a "Moderate Buy" consensus rating from analysts, the stock is trading near its 52-week low. The company recently reported …

Nova (NVMI) Is Up 7.9% After Strong Q2 Beat And Confident Q3 Guidance – What's Changed

Nova (NVMI) recently reported strong Q2 2026 results, exceeding revenue and net income expectations, and provided confident Q3 guidance. This performance suggests management's belief in current semiconductor process-control demand and reinforces the investment narrative around increasing complexity in chip manufacturing. However, the company still …

T. Rowe Price Associates (THG) discloses 5.2% Hanover Insurance ownership stake

T. Rowe Price Associates, Inc. has reported a 5.2% beneficial ownership stake in Hanover Insurance Group Inc., holding 1,831,584 shares. The firm exercises sole voting power over 1,819,788 shares and sole dispositive power over all 1,831,584 shares. T. Rowe Price Associates explicitly denies that …

T. Rowe Price (NOVT) discloses 6.2% beneficial stake in Novanta common stock

T. Rowe Price Associates, Inc. has disclosed a 6.2% beneficial ownership stake in Novanta Inc. (NOVN), amounting to 2,222,444 shares of common stock. The firm reported sole voting power over 2,216,715 shares and sole dispositive power over all 2,222,444 shares, while explicitly denying that …

Why GE Vernova (GEV) Is Emerging as an AI Power Winner

Polen Capital Management Llc released its "Polen Focus Growth Strategy" Q2 2026 investor letter. A copy of the letter can be downloaded here. Polen Focus Growth returned 6.33% (net of fees) in the second quarter of 2026, significantly underperforming the Russell 1000 Growth Index's …

Eden Innovations Ltd Company Profile & Introduction

Why Novo Resources Corp stock surged yesterday

Cenovus Energy (NYSE:CVE) Clears the Minervini Trend Template and High-Growth Momentum Screen

Innovative Eyewear CEO to present at Sidoti's Micro-Cap Virtual Investor Conference on Aug 19-20, 2026

Innovative Eyewear, known for its AI-enabled smart glasses under brands like Lucyd and Reebok, announced that CEO Harrison Gross will present and meet with investors at Sidoti's Micro-Cap Virtual Investor Conference on August 19-20, 2026. This participation underscores the company's commitment to investor engagement …

init innovation Aktie: Drei Kaufempfehlungen und bis zu 68 Euro Kursziel

Jefferies Remains a Hold on Bank Of Nova Scotia (BNS)

Jefferies analyst John Aiken maintained a Hold rating on Bank Of Nova Scotia (BNS) with a price target of C$117.00. Aiken, a 3-star analyst, covers the Financial sector and has an average return of 0.7% with a 51.23% success rate. This assessment follows a …

Annovis expects October study to let Alzheimer’s patients continue treatment

Annovis (NYSE: ANVS) reported Q2 2026 results, highlighting that its pivotal Phase 3 early Alzheimer’s trial is fully enrolled with 850 patients and an open-label extension for Alzheimer's patients is planned for October 2026. The company also provided updates on its Parkinson's open-label extension, …

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Annovis Bio, Inc. announced significant clinical advancements and its second-quarter 2026 financial results. The company has fully enrolled its pivotal Phase 3 Alzheimer's disease trial with 850 patients, exceeding original projections, and is progressing with its Parkinson's disease open-label extension study. Annovis plans to …

Could AI Infrastructure Fuel GE Vernova’s (GEV) Next Rally?

Parnassus Investments, an investment management company, released the "Parnassus Core Equity Fund" second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500's 15.20% gain. Performance …

Signaturefd LLC Buys 22,148 Shares of Novo Nordisk A/S $NVO

Saratoga Research & Investment Management Sells 200,320 Shares of Novo Nordisk A/S $NVO

Mirae Asset Global Investments Co. Ltd. Purchases 56,424 Shares of Novartis AG $NVS

Mirae Asset Global Investments Co. Ltd. significantly increased its stake in Novartis AG (NVS) by 40.4% in the second quarter, acquiring an additional 56,424 shares, bringing its total holdings to 195,986 shares valued at approximately $30.7 million. Other institutional investors also expanded their positions, …

Mirae Asset Global Investments Co. Ltd. Increases Stake in Novo Nordisk A/S $NVO